Skip to main content

Advertisement

Table 1 General preoperative conditions of patients

From: A clinical analysis of vitrectomy for severe vitreoretinopathy in patients with chronic renal

No HBp DM RD Treatment Hb GHb Scr SK echocardiography EF
(years) (years) (years) (g/L) (%) (μmol/L) (mmol/L) (%)
1 10 20 2 HD 120 7.5 596.3 5.6 b,c,d,e,f 36
2 5 24 3 HD 87 6.8 712 5.3 a,b,d,e 52
3 0.3 20 1 Drug 128 8.7 422 4.8 a,b,c 58
4 13 15 2 HD 79 6.2 860 4.8 a,b,d,e 52
5 12 25 3 HD 117 7.6 720 4.2 a,b,e 51
6 7 12 9 PD 107 6.4 650 6.2 a,b,d,e 52
7 10 16 6 Drug 112 5.8 249 5.8 a,b,d,e 54
8 10 10 4 HD 89 5.4 1095 4.7 a,b,c,d 54
9 10 22 3 PD 102 6.5 771 4.1 a,b,d 50
10 1 13 1 HD 107 7.1 1081 5.3 a,b 68
11 1 13 1 HD 95 6.8 1029 5.1 a,b 68
12 1 1 1 HD 80 6.2 893 5.5 a,b,e 58
13 5 10 5 Drug 98 7.5 493 4.6 a,b,d 60
14 3 24 4 HD 128 9.5 691 5.6 a,b,e 60
15 10 0 0.3 HD 109 4.5 459 4.3 a,b,e 62
16 15 0 4 Drug 122 4.8 243 5.1 a,b 65
  1. HBp hypertension, DM diabetic mellitus, RD renal disease, Hb hemoglobin, GHb glycolated hemoglobin, HD hemodialysis, PD peritoneal dialysis, Scr serum creatinine, SK Serum kalium, EF ejection fraction, a Left atrial enlargement, b Left ventricular dysfunction, c pulmonary arterial hypertension, d hydropericardium, e aortic valve calcification, f cardiomegaly